Volume 18, Issue 5, Pages (May 2011)

Slides:



Advertisements
Similar presentations
Volume 18, Issue 11, Pages (November 2011)
Advertisements

Volume 20, Issue 2, Pages (February 2012)
Volume 6, Issue 2, Pages (February 1998)
Volume 98, Issue 3, Pages (February 2010)
Natalie K. Garcia, Miklos Guttman, Jamie L. Ebner, Kelly K. Lee 
R. Andrew Marshall, Colin Echeverría Aitken, Joseph D. Puglisi 
Interaction of Era with the 30S Ribosomal Subunit
Kirill B. Gromadski, Marina V. Rodnina  Molecular Cell 
Volume 60, Issue 3, Pages (November 2015)
A Corkscrew Model for Dynamin Constriction
Volume 16, Issue 10, Pages (October 2009)
Mahmoud Ghanem, Andrew S. Murkin, Vern L. Schramm  Chemistry & Biology 
Andrey V. Zavialov, Vasili V. Hauryliuk, Måns Ehrenberg  Molecular Cell 
Finding the Missing Code of RNA Recognition by PUF Proteins
Volume 113, Issue 11, Pages (December 2017)
Volume 42, Issue 3, Pages (May 2011)
Microfluidic Compartmentalized Directed Evolution
Volume 11, Issue 6, Pages (June 2003)
Volume 24, Issue 12, Pages (December 2016)
Complex Energy Landscape of a Giant Repeat Protein
Kinetic Discrimination of tRNA Identity by the Conserved Motif 2 Loop of a Class II Aminoacyl-tRNA Synthetase  Ethan C. Guth, Christopher S. Francklyn 
Volume 127, Issue 4, Pages (November 2006)
Hani S. Zaher, Rachel Green  Molecular Cell 
Matthew Levy, Andrew D. Ellington  Chemistry & Biology 
Volume 13, Issue 1, Pages (January 2004)
Volume 20, Issue 2, Pages (February 2012)
Volume 130, Issue 6, Pages (September 2007)
Probing Translation with Small-Molecule Inhibitors
Volume 23, Issue 10, Pages (October 2016)
Volume 35, Issue 1, Pages (July 2009)
Trapping the Ribosome to Control Gene Expression
Structure-Guided Design of Fluorescent S-Adenosylmethionine Analogs for a High- Throughput Screen to Target SAM-I Riboswitch RNAs  Scott F. Hickey, Ming C.
Volume 25, Issue 12, Pages e3 (December 2017)
Structures of Minimal Catalytic Fragments of Topoisomerase V Reveals Conformational Changes Relevant for DNA Binding  Rakhi Rajan, Bhupesh Taneja, Alfonso.
Volume 57, Issue 3, Pages (February 2015)
Volume 56, Issue 4, Pages (November 2014)
A Subdomain Swap Strategy for Reengineering Nonribosomal Peptides
Broad-Spectrum Antibiotic Activity of the Arylomycin Natural Products Is Masked by Natural Target Mutations  Peter A. Smith, Tucker C. Roberts, Floyd.
Structural Basis for the Differential Effects of CaBP1 and Calmodulin on CaV1.2 Calcium-Dependent Inactivation  Felix Findeisen, Daniel L. Minor  Structure 
Volume 23, Issue 5, Pages (May 2015)
Volume 4, Issue 11, Pages (November 1996)
Volume 22, Issue 1, Pages (January 2015)
Volume 6, Issue 2, Pages (January 2014)
Volume 129, Issue 5, Pages (June 2007)
Jinzhong Lin, Matthieu G. Gagnon, David Bulkley, Thomas A. Steitz  Cell 
Volume 20, Issue 1, Pages (January 2013)
Volume 20, Issue 1, Pages (July 2017)
The Pathway of HCV IRES-Mediated Translation Initiation
Volume 20, Issue 2, Pages (February 2013)
Volume 58, Issue 5, Pages (June 2015)
Volume 16, Issue 6, Pages (December 2004)
Saccharomyces cerevisiae Ski7 Is a GTP-Binding Protein Adopting the Characteristic Conformation of Active Translational GTPases  Eva Kowalinski, Anthony.
Volume 56, Issue 3, Pages (November 2014)
Volume 16, Issue 8, Pages (August 2016)
Volume 15, Issue 8, Pages (August 2008)
Volume 30, Issue 1, Pages (April 2008)
Volume 121, Issue 5, Pages (June 2005)
Volume 26, Issue 1, Pages (April 2007)
DNA Unwinding Is the Primary Determinant of CRISPR-Cas9 Activity
Volume 18, Issue 12, Pages (December 2011)
Volume 19, Issue 5, Pages (May 2012)
Volume 6, Issue 2, Pages (August 2000)
Sequence of Steps in Ribosome Recycling as Defined by Kinetic Analysis
Mahmoud Ghanem, Andrew S. Murkin, Vern L. Schramm  Chemistry & Biology 
Volume 21, Issue 10, Pages (October 2014)
Volume 10, Issue 8, Pages (August 2003)
Volume 100, Issue 3, Pages (February 2000)
Empty Site Forms of the SRP54 and SRα GTPases Mediate Targeting of Ribosome– Nascent Chain Complexes to the Endoplasmic Reticulum  Peter J Rapiejko, Reid.
Volume 125, Issue 6, Pages (June 2006)
Ribosomal translocation: EF-G turns the crank
Presentation transcript:

Volume 18, Issue 5, Pages 589-600 (May 2011) Differential Effects of Thiopeptide and Orthosomycin Antibiotics on Translational GTPases  Aleksandra Mikolajka, Hanqing Liu, Yuanwei Chen, Agata L. Starosta, Viter Márquez, Marina Ivanova, Barry S. Cooperman, Daniel N. Wilson  Chemistry & Biology  Volume 18, Issue 5, Pages 589-600 (May 2011) DOI: 10.1016/j.chembiol.2011.03.010 Copyright © 2011 Elsevier Ltd Terms and Conditions

Chemistry & Biology 2011 18, 589-600DOI: (10. 1016/j. chembiol. 2011 Copyright © 2011 Elsevier Ltd Terms and Conditions

Figure 1 Chemical Structures and Ribosomal-Binding Sites of Thiopeptide and Orthosomycin Antibiotics (A–C) Chemical structures of the (A) orthosomycin Evn, and the thiopeptide antibiotics (B) ThS and (C) MiC. (D) Overview of the binding sites of orthosomycins and thiopeptides on the large subunit relative to EF-G. R-proteins L1, L11, and L7 are shown for reference. (E) Putative binding site of orthosomycins spanning from H89 and H91 of the 23S rRNA. Residues highlighted in red have been associated biochemically with Evn or Avn (reviewed by Wilson, 2009). (F) Binding site of ThS (green) in the cleft between H43 and H44 of the 23S rRNA and the NTD of L11 (L11-ThS) (Harms et al., 2008). The relative positions of EF-G (blue), C-terminal domain of L7/L12 (L7-CTD), and of a different conformation of L11 (L11-EF-G) are from Gao et al. (2009). (G) Overview of domain arrangement of EF-G with contact between the L7-CTD and the G′ domain of EF-G as observed in the 70S-EF-G crystal structure (Gao et al., 2009). (H) Expansion of (G) highlighting the secondary structure elements of the G′ subdomain. (I) Juxtaposition of the G′ subdomain of EF-G (gray transparency) with the G-domain of EF4 (orange) (Evans et al., 2008) that lacks a G′ subdomain. See also Figure S1. Chemistry & Biology 2011 18, 589-600DOI: (10.1016/j.chembiol.2011.03.010) Copyright © 2011 Elsevier Ltd Terms and Conditions

Figure 2 Effect of ThS and MiC on GTPase Activity of Various Translation Factors (A–F) The rdGTPase activities of translation factors (A) E. coli EF-G, (B) TetM, (C) E. coli EF4, (D) E. coli BipA, (E) E. coli IF2, and (F) E. coli EF-GΔG′, using E. coli 70S ribosomes in the absence (black circles) and presence of 1 μM ThS (red squares) or 5 μM MiC (blue triangles). (G–I) The rdGTPase activities of E. coli translation factors (G) EF-G, (H) EF4, and (I) BipA, using E. coli 70S ribosomes lacking L7/L12. Reactions in (G)–(I) were incubated for 12 hr at 20°C. In all cases, background hydrolysis due to the intrinsic GTPase activity of each factor has been subtracted. See also Figure S2. Chemistry & Biology 2011 18, 589-600DOI: (10.1016/j.chembiol.2011.03.010) Copyright © 2011 Elsevier Ltd Terms and Conditions

Figure 3 Effect of the MiC and Evn on Translocation (A) Scheme for EF-G catalyzed translocation with sites of antibiotic inhibition. (B) Isolated PRE complex (0.1 μM) containing yeast fMetPhe-tRNAPhe(Prf16/17) in the A site and tRNAfMet in the P site, either in the absence of antibiotic (black trace) or in the presence of ThS (10 μM; red trace) or MiC (10 μM; blue trace), was rapidly mixed in a stopped-flow spectrophotometer with 5 μM EF-G and 1 mM GTP. (C) Isolated PRE complex (0.1 μM) containing E. coli fMetPhe-tRNAPhe(Prf16/20) and tRNAfMet in the P site, in the absence of antibiotic (black trace) or in the presence of Evn (10 μM; green trace) or MiC (10 μM; blue trace), was rapidly mixed in a stopped-flow spectrophotometer with 5 μM EF-G and 1 mM GTP. All concentrations are final after mixing. The traces in the control and +Evn traces are each fit to a two-step process (Pan et al., 2007) yielding the following rate constants: Control: 20.7 ± 0.6 s−1, 1.3 ± 0.1 s−1; +Evn: 28.1 ± 0.7 s−1, 3.5 ± 0.2 s−1. See also Figure S3. Chemistry & Biology 2011 18, 589-600DOI: (10.1016/j.chembiol.2011.03.010) Copyright © 2011 Elsevier Ltd Terms and Conditions

Figure 4 Evn Inhibits IF2-Dependent 70SIC Formation (A) Scheme for 70SIC formation with site of Evn inhibition. (B) 30SIC (0.3 μM) was premixed with various concentrations of Evn (0–5 μM) and then rapidly mixed with 50S subunits (0.3 μM) in a KinTek stopped-flow spectrophotometer. The sample from which IF2 was omitted demonstrates the dependence of 70SIC formation on IF2. (C) A plot of the reciprocal of IF2-dependent light-scattering increase at 1 s versus Evn concentration, allowing calculation of an apparent Ki for Evn of 1.8 ± 0.2 μM. Chemistry & Biology 2011 18, 589-600DOI: (10.1016/j.chembiol.2011.03.010) Copyright © 2011 Elsevier Ltd Terms and Conditions

Figure 5 Effect of Evn on the GTPase Activity of Various Translation Factors (A–F) Activation of uncoupled rdGTPases of translation factors (A) E. coli IF2, (B) E. coli EF-G, (C) E. coli EF-GΔG′, (D) S. faecalis TetM, (E) E. coli BipA, and (F) E. coli EF4, in the presence of increasing concentrations of Evn. The inset shows the color gradient scale from 0 (yellow) to 800 pmol (blue) of Pi produced per pmol of 70S ribosomes, following subtraction of background intrinsic GTPase activities. Chemistry & Biology 2011 18, 589-600DOI: (10.1016/j.chembiol.2011.03.010) Copyright © 2011 Elsevier Ltd Terms and Conditions

Figure 6 Evn Inhibits EF4-Mediated Back-Translocation (A) Scheme for EF4-catalyzed back-translocation with sites of antibiotic inhibition. (B) Fluorescence changes over different time scales. Isolated POST complex (0.1 μM) containing fMetPhe-tRNAPhe(Prf) in the P site and tRNAfMet in the E site, premixed with 0.15 μM tRNAfMet, to increase E-site occupancy, were rapidly mixed in a stopped-flow spectrophotometer with 3 μM EF4, 0.5 mM GDPNP, and different concentrations of Evn as indicated on the figure. All concentrations are final after mixing. Lines through the traces are fit to a kinetic model (Liu et al., 2010) in which back-translocation proceeds via a three-step process in the absence of Evn (the first two of which are catalyzed by EF4) and via a two-step process at saturating Evn. (C) A plot of the reciprocal of the apparent magnitude of the fluorescence change for the second, EF4-catalyzed step versus Evn concentration, giving an apparent Ki for Evn binding to the POST complex of 0.6 ± 0.1 μM. Chemistry & Biology 2011 18, 589-600DOI: (10.1016/j.chembiol.2011.03.010) Copyright © 2011 Elsevier Ltd Terms and Conditions

Figure 7 Putative Binding Sites of Orthosomycin Antibiotics Relative to Translation Factors EF-G, EF4, and IF2 (A–C) Relative position of (A) EF-G (blue) (Connell et al., 2007; Gao et al., 2009), (B) EF4 (orange) (Connell et al., 2008), and (C) IF2 (purple) (Allen et al., 2005; Marzi et al., 2003) to the putative Evn-binding site (encircled in red) (Belova et al., 2001; Wilson, 2009). Nucleotides associated with Evn binding in H89 and H91 are colored red, and L16 (teal) is shown for reference. Note the overlap in positions of the CTD of EF4 and domain 4 (d4) of IF2 with the putative Evn-binding site. Chemistry & Biology 2011 18, 589-600DOI: (10.1016/j.chembiol.2011.03.010) Copyright © 2011 Elsevier Ltd Terms and Conditions